Symbolbild · KI-generiert
COSCIENS Biopharma Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
COSCIENS is a holding company, operating through its subsidiaries. COSCIENS's principal operating subsidiary, Ceapro Inc. ('Ceapro') is focused on the development and commercialization of natural, plant-based active ingredients derived from oats and other renewable plant resources, using proprietary manufacturing and extraction technologies. Ceapro's primary active ingredient business activities relate to the development and commercialization of natural products for personal care, cosmetic, human and animal health industries using proprietary technology, natural, renewable resources and developing innovative products, technologies and delivery systems.
Company description as published by the issuer via TMX Money.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| COSCIENS Biopharma Inc. | CSCI | TSX | 5 Mio. USD |
| QScreen AI Inc. | QAI | CSE | 5 Mio. USD |
| WestBond Enterprises Corporation | WBE | TSXV | 5 Mio. USD |
| Zimtu Capital Corp. | ZC | TSXV | 6 Mio. USD |
| Blueberries Medical Corp. | BBM | CSE | 6 Mio. USD |
| Avricore Health Inc. | AVCR | TSXV | 5 Mio. USD |
| Advent-AWI Holdings Inc. | AWI | TSXV | 5 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.